Medicus Pharma Ltd. Common Stock
MDCX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23,375 | $9,221 | $5,115 | $21,329 |
| - Cash | $4,164 | $1,719 | $268 | $79 |
| + Debt | $322 | $0 | $1,531 | $668 |
| Enterprise Value | $19,533 | $7,501 | $6,379 | $21,919 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,156 | -$587 | -$1,166 | -$1,940 |
| % Margin | – | – | – | – |
| Net Income | -$11,156 | -$5,315 | -$1,692 | -$2,055 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.1 | -1.53 | -0.21 | -0.26 |
| % Growth | 28.1% | -628.6% | 19.2% | – |
| Operating Cash Flow | -$10,247 | -$4,158 | -$1,057 | -$1,448 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10,247 | -$4,158 | -$1,057 | -$1,448 |